KIF2C

Across TCGA pan-cancer cohorts, KIF2C RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of KIF2C’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where KIF2C RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KIF2C is over-expressed in tumor.

HNSC, LUAD, and BLCA are the cancer types where KIF2C tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KIF2C RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+2.282	<.001	12	view →
LUAD	Male	III,IV	+3.546	<.001	11	view →
BLCA	Male	III,IV	+3.475	<.001	11	view →
COAD	Female	II,III,IV	+1.659	<.001	11	view →
KIRP	All	III,IV	+1.630	<.001	11	view →
KIRC	Male	IV	+1.358	<.001	11	view →
STAD	Female	All	+2.724	<.001	9	view →
LIHC	Female	II,III,IV	+2.299	<.001	9	view →
LUSC	Male	III,IV	+4.327	<.001	8	view →
UCEC	All	III,IV	+3.838	<.001	8	view →
BRCA	All	II,III,IV	+2.588	<.001	6	view →
CHOL	Male	All	+4.140	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

KIF2C–HNSC

Open the HNSC breakdown →